Login / Signup

PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients.

Tanita SuttichaimongkolManoon MitprachaKawin TangvoraphonkchaiPhuangphaka SadeeKittisak SawanyawisuthWattana Sukeepaisarnjaroen
Published in: Journal of circulating biomarkers (2023)
PIVKA-II may have more diagnostic yield for HCC compared with AFP. It can be used alone without a combination with AFP.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis